Biotech Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) May 14, 2025
Biotech Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology May 13, 2025
Biotech Alphyn Doses First Patients in CLEAR-AD1 Global Phase 2b Clinical Trial Program for Atopic Dermatitis May 12, 2025
Biotech Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 May 11, 2025
Biotech Anivive’s Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025 May 10, 2025
Biotech LEQVIO Strengthens Position as Leader in Cholesterol-Lowering Therapies Across Seven Major Markets | DelveInsight May 9, 2025
Biotech The Galien Foundation Announces 2025 Prix Galien UK Forum and Awards Ceremony in London on 5 June May 8, 2025
Biotech Benuvia Operations Signs Research & Development and Manufacturing Agreement with Trait Biosciences to Advance Next-Generation Cannabinoid-Based Products May 7, 2025
Biotech Elsevier adds half a million records from ClinicalTrials.gov to Embase, enabling a seamless search experience in the world’s most comprehensive biomedical database May 6, 2025
Search
Biotech
May 14, 2025
May 13, 2025
May 12, 2025
May 11, 2025
May 10, 2025
May 9, 2025
May 8, 2025
May 7, 2025
May 6, 2025
May 5, 2025
